AYTU's logo.
Ticker Symbol: AYTU

Aytu BioPharma Inc

$2.21 - 09-10-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001385818

Company Profile

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved radioimaging agent indicated to detect prostate specific membrane antigen (psma) in the assessment and staging of prostate cancer. the company’s most advanced therapeutic is zertane™, an oral therapeutic entering phase 3 clinical studies in the united states as an as needed treatment for premature ejaculation (pe). aytu is also conducting clinical trials with the company’s mioxsys™ system as a novel, point-of-care diagnostic system with the potential to become a standard of care in the diagnosis and management of male infertility.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 16200 W County Road 18 E
Website: N/A
CEO: N/A
Tags:
  • Consumer Services
  • Other Consumer Services
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.14
Change: -$0.18 ( -5.42%)
Days Range: $2.87 - $3.46
Beta: 0.47
52wk. High: $4.88
52wk. Low: $1.38
Ytd. Change -22.35%
50 Day Moving Average: $2.27
200 Day Moving Average: $1.97
Shares Outstanding: 5530027

Valuation

Market Cap: 1.7B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A